Preclinical anticancer activity of LSZ102, a novel oral selective estrogen receptor degrader targeting wild-type and mutant ER Meeting Abstract
| Authors: | Gaither, L. A.; Yip, C. L. T.; Wang, C.; Toy, W.; Sheng, Q.; Chen, J.; Mishina, Y.; Das, R.; Peukert, S.; Loo, A.; Chandarlapaty, S.; Crystal, A.; Abrams, T. J. |
| Abstract Title: | Preclinical anticancer activity of LSZ102, a novel oral selective estrogen receptor degrader targeting wild-type and mutant ER |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129903022 |
| DOI: | 10.1158/1538-7445.Am2019-922 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 922 -- Source: Wos |
